Letters in Drug Design and Discovery : Impact Factor & More
eISSN: 1875-628XpISSN: 1570-1808
Share this on:
Key Metrics
CiteScore 
2.2
Impact Factor
< 5
SJR
Q4Drug Discovery
SNIP
0.38
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Letters in Drug Design and Discovery
Letters in Drug Design and Discovery Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Letters in Drug Design and Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Letters in Drug Design and Discovery
Synthesis of new metacetamol azo derivatives and assessment of their antibacterial and pharmacological potential
- 1 Apr 2026
- Letters in Drug Design & Discovery
Network pharmacology combined with pharmacology to explore the mechanism of Zengye Runzao Decoction in treating Sjögren's Syndrome
- 1 Apr 2026
- Letters in Drug Design & Discovery
C-di-AMP analogs as allosteric inhibitors against tuberculosis: A 500 ns molecular dynamics study
- 1 Apr 2026
- Letters in Drug Design & Discovery
Computational study of Fostemsavir reactivity to understand its degradation properties and its intrinsic stability through DFT and MD approach
- 1 Mar 2026
- Letters in Drug Design & Discovery
Advances in stem cell therapy, nanomedicine, multi-omics, and artificial intelligence–assisted strategies for the treatment of lung injury and pulmonary fibrosis
- 1 Mar 2026
- Letters in Drug Design & Discovery
Structure-based drug designing and pharmacological profiling of Withanolide A as potential EGFR inhibitors for glioblastoma treatment
- 1 Mar 2026
- Letters in Drug Design & Discovery
Synthesis of new metacetamol azo derivatives and assessment of their antibacterial and pharmacological potential
- 1 Apr 2026
- Letters in Drug Design & Discovery
Network pharmacology combined with pharmacology to explore the mechanism of Zengye Runzao Decoction in treating Sjögren's Syndrome
- 1 Apr 2026
- Letters in Drug Design & Discovery
C-di-AMP analogs as allosteric inhibitors against tuberculosis: A 500 ns molecular dynamics study
- 1 Apr 2026
- Letters in Drug Design & Discovery
Computational study of Fostemsavir reactivity to understand its degradation properties and its intrinsic stability through DFT and MD approach
- 1 Mar 2026
- Letters in Drug Design & Discovery
Advances in stem cell therapy, nanomedicine, multi-omics, and artificial intelligence–assisted strategies for the treatment of lung injury and pulmonary fibrosis
- 1 Mar 2026
- Letters in Drug Design & Discovery
Structure-based drug designing and pharmacological profiling of Withanolide A as potential EGFR inhibitors for glioblastoma treatment
- 1 Mar 2026
- Letters in Drug Design & Discovery
FAQs on Letters in Drug Design and Discovery
How long has Letters in Drug Design and Discovery been actively publishing? 
What is the publishing frequency of Letters in Drug Design and Discovery?
How many articles did Letters in Drug Design and Discovery publish last year?
What is the eISSN & pISSN for Letters in Drug Design and Discovery?
What is Citescore for Letters in Drug Design and Discovery?
What is SNIP score for Letters in Drug Design and Discovery?
What is the SJR for Letters in Drug Design and Discovery?
Who is the publisher of Letters in Drug Design and Discovery?
